Alphabiome Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Early Stage VC
  • (Upcoming)

  • Investors
  • 6

Alphabiome General Information

Description

Developer of an agricultural technology platform designed to address the environmental issues associated with bovine methane production. The company's platform partners with farmers and other stakeholders in the meat and dairy industry to globally expand the deployment of our novel microbiome analytics technology individually customized for each herd and can predict the impact of specific feedstock on methane production and match herds of cattle with feedstock designed to reduce that production based on particular microbiome considerations, enabling dairy and cattle farmers produce quality food in sustainable ways by reducing their methane emissions and monetizing their carbon credits.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Horesh Alonim 2
  • PO Box 2552
  • Ramat Yishai
  • Israel
+972
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • Horesh Alonim 2
  • PO Box 2552
  • Ramat Yishai
  • Israel
+972

Alphabiome Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alphabiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC Upcoming Generating Revenue
4. Seed Round 06-May-2025 Completed Generating Revenue
3. Seed Round 01-Sep-2024 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Seed Round 01-Jan-2023 Completed Generating Revenue
To view Alphabiome’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Alphabiome Patents

Alphabiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025052372-A1 Efficient detection of decentralized biomarkers of groups of dna sequences in microbiome dna Inactive 08-Sep-2023

Alphabiome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alphabiome Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
iSelect Fund Venture Capital Minority
Newland Syndicate Venture Capital Minority
AIX Ventures Venture Capital Minority
New Era Capital Partners Venture Capital Minority
Visionary Future (Inv) Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

Alphabiome FAQs

  • When was Alphabiome founded?

    Alphabiome was founded in 2022.

  • Where is Alphabiome headquartered?

    Alphabiome is headquartered in Ramat Yishai, Israel.

  • What is the size of Alphabiome?

    Alphabiome has 17 total employees.

  • What industry is Alphabiome in?

    Alphabiome’s primary industry is Discovery Tools (Healthcare).

  • Is Alphabiome a private or public company?

    Alphabiome is a Private company.

  • What is Alphabiome’s current revenue?

    The current revenue for Alphabiome is .

  • How much funding has Alphabiome raised over time?

    Alphabiome has raised $8M.

  • Who are Alphabiome’s investors?

    iSelect Fund, Newland Syndicate, AIX Ventures, New Era Capital Partners, and Visionary Future (Inv) are 5 of 6 investors who have invested in Alphabiome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process